| pubmed-article:19144444 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19144444 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19144444 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:19144444 | lifeskim:mentions | umls-concept:C0920317 | lld:lifeskim |
| pubmed-article:19144444 | lifeskim:mentions | umls-concept:C0032207 | lld:lifeskim |
| pubmed-article:19144444 | lifeskim:mentions | umls-concept:C0078257 | lld:lifeskim |
| pubmed-article:19144444 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:19144444 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:19144444 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:19144444 | pubmed:dateCreated | 2009-8-3 | lld:pubmed |
| pubmed-article:19144444 | pubmed:abstractText | Whether platinum plus gemcitabine or vinorelbine are equally effective in the treatment of advanced non-small-cell lung cancer (NSCLC) is still controversial, a meta-analysis was performed to compare the gemcitabine plus platinum with vinorelbine plus platinum regimens in first-line treatment of advanced NSCLC. | lld:pubmed |
| pubmed-article:19144444 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19144444 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19144444 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19144444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19144444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19144444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19144444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19144444 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19144444 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19144444 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19144444 | pubmed:issn | 1872-8332 | lld:pubmed |
| pubmed-article:19144444 | pubmed:author | pubmed-author:ZhaohuiChuC | lld:pubmed |
| pubmed-article:19144444 | pubmed:author | pubmed-author:JiangJingweiJ | lld:pubmed |
| pubmed-article:19144444 | pubmed:author | pubmed-author:LiangXiaohuaX | lld:pubmed |
| pubmed-article:19144444 | pubmed:author | pubmed-author:ZhouXinliX | lld:pubmed |
| pubmed-article:19144444 | pubmed:author | pubmed-author:HuangRuofanR | lld:pubmed |
| pubmed-article:19144444 | pubmed:author | pubmed-author:GaoGuanghuiG | lld:pubmed |
| pubmed-article:19144444 | pubmed:author | pubmed-author:ZhanQiongQ | lld:pubmed |
| pubmed-article:19144444 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19144444 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:19144444 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19144444 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19144444 | pubmed:pagination | 339-44 | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:meshHeading | pubmed-meshheading:19144444... | lld:pubmed |
| pubmed-article:19144444 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19144444 | pubmed:articleTitle | A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer. | lld:pubmed |
| pubmed-article:19144444 | pubmed:affiliation | Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China. | lld:pubmed |
| pubmed-article:19144444 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19144444 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19144444 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
